Mark Ragosa
Director of Finance/CFO at KINIKSA PHARMACEUTICALS, LTD.
Net worth: 339 045 $ as of 2024-04-29
Mark Ragosa active positions
Companies | Position | Start | End |
---|---|---|---|
KINIKSA PHARMACEUTICALS, LTD. | Director of Finance/CFO | 2020-12-16 | - |
Investor Relations Contact | 2018-04-30 | 2021-02-28 | |
Public Communications Contact | 2018-04-30 | 2021-02-28 | |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Director/Board Member | - | - |
Director of Finance/CFO | - | - |
Career history of Mark Ragosa
Former positions of Mark Ragosa
Companies | Position | Start | End |
---|---|---|---|
IRONWOOD PHARMACEUTICALS, INC. | Investor Relations Contact | 2016-08-31 | 2018-04-30 |
Corporate Officer/Principal | 2016-08-31 | 2018-01-31 | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - | - |
Training of Mark Ragosa
Bowdoin College | Undergraduate Degree |
Statistics
International
United States | 5 |
Bermuda | 2 |
Operational
Director of Finance/CFO | 2 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Health Technology |
- Stock Market
- Insiders
- Mark Ragosa
- Experience